Cabo Verde: COVID-19 Emergency Response Project

Abstract*

This Project Appraisal Document (PAD) describes the emergency response in Cabo Verde under the COVID-19 Strategic Preparedness And Response Program (SPRP) using the Multi-phase Programmatic Approach (MPA), approved by the World Bank’s Board of Executive Directorson March 20, 2020. The Project is structured around two complementary components, which will support the Government of Cabo Verde in the implementation of its National COVID-19 Preparedness... Show More

Development Objective

Project development objective is to prepare and respond to the COVID-19 pandemic in Cabo Verde

Key Details

Project Details

Project ID
P173857
Status
Active
Team Leader
Andre Carletto
Borrower 2
Ministério das Finanças

Country
Cabo Verde
Disclosure Date
March 25, 2020
Approval Date
(as of board presentation)
April 2, 2020
Effective Date
April 9, 2020

Total Project Cost 1
US$ 5.00 million
Implementing Agency
National Health Directorate
Region
Western and Central Africa
Fiscal Year 3
2020

Commitment Amount
US$ 5.00 million
Environmental Category
N/A
Last Update Date
April 12, 2024
Closing Date
December 31, 2025

Consultant Services required
No
Last Stage Reached
BANK APPROVED

Associated Projects
P177181
P175807
P174299

Notes
1. Total project cost includes funding from World Bank and non-bank sources in US$ millions. Active and Closed projects show current commitments. Proposed (pipeline) and dropped projects show the forecast amount. The commitment amount for projects in the pipeline is indicative and may be modified during the project preparation.
2. Borrower refers to the Borrower of a Loan or Recipient of a Grant.
3. ”Fiscal Year” is the fiscal year in which the project was approved (or dropped if the status is dropped). The World Bank's fiscal year is from July 1 - June 30. For example, a fiscal year of 1996 corresponds to July 1, 1995 - June 30, 1996.

Sectors

Themes

FY17 - Human Development and Gender

FY17 - Disease Control100%
- FY17 - Pandemic Response100%
FY17 - Health Systems and Policies100%
- FY17 - Health Service Delivery100%
- FY17 - Health System Strengthening100%

Project Map

Interactive Map

Finances

Financing Plan (US$ Millions)

Financier	Commitments
IDA Credit	5.00

Total Project Financing (US$ Millions)

Product Line	IBRD/IDA
IBRD Commitment	N/A
IDA Commitment	5.00
IBRD + IDA Commitment	5.00

Lending Instrument
Grant Amount	N/A
Total Project Cost**	5.00

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

No data available.

Detailed Financial Activity as of March 31, 2025

Download:

Period	Financier	Transaction Type	Amount (US$)
Dec 15, 2023	IDA-68370	Int Charges	16,953.77
Dec 15, 2023	IDA-65970	Int Charges	287.44
Jun 7, 2023	IDA-68370	Loan Disb	153,902.12
Jun 7, 2023	IDA-68370	Loan Disb	25,267.13
Jul 10, 2023	IDA-68370	Loan Disb	22,068.91
Jun 15, 2023	IDA-68370	Int Charges	916.01
Jun 15, 2023	IDA-68370	Int Charges	916.01
Jun 15, 2023	IDA-68370	Int Charges	16,293.59
Jun 15, 2023	IDA-68370	Int Charges	16,293.59
Jun 26, 2023	IDA-69770	Loan Cancel	5,010,597.00
Feb 3, 2023	IDA-68370	Loan Disb	98,685.77
Feb 3, 2023	IDA-68370	Loan Disb	112,315.36
Dec 15, 2022	IDA-65970	Int Charges	17,183.29
Dec 15, 2022	IDA-65970	Int Charges	17,183.29
Dec 15, 2022	IDA-65970	Int Charges	478.44
Dec 15, 2022	IDA-65970	Int Charges	478.44
Feb 8, 2023	IDA-68370	Loan Disb	262,200.56
Jun 15, 2023	IDA-65970	Int Charges	753.60
Nov 14, 2022	IDA-68370	Loan Disb	83,006.75
Nov 14, 2022	IDA-68370	Loan Disb	32,857.94
Jun 15, 2024	IDA-69770	Int Charges	2,229.43
Jun 15, 2024	IDA-68370	Int Charges	17,276.26
Jun 15, 2024	IDA-68370	Int Charges	17,276.26
Jun 15, 2024	IDA-65970	Int Charges	419.73
Jun 15, 2024	IDA-65970	Int Charges	419.73
Jun 15, 2024	IDA-65970	Int Charges	18,212.97
Dec 15, 2023	IDA-65970	Int Charges	287.44
Feb 27, 2024	IDA-69770	Loan Disb	1,000,000.00
Jun 15, 2024	IDA-65970	Int Charges	18,212.97
Jun 15, 2024	IDA-68370	Int Charges	397.89
Jun 15, 2024	IDA-68370	Int Charges	397.89
Jun 15, 2024	IDA-69770	Int Charges	2,229.43
Feb 11, 2021	IDA-68370	Loan Commitment	5,000,000.00
Jun 29, 2021	IDA-69770	Loan Commitment	10,000,000.00
Apr 2, 2020	IDA-65970	Loan Commitment	5,000,000.00
Dec 15, 2020	IDA-65970	Int Charges	16,430.99
Dec 15, 2020	IDA-65970	Int Charges	16,430.99
Oct 8, 2020	IDA-65970	Loan Disb	409,853.44
Sep 20, 2021	IDA-68370	Loan Disb	206,245.23
Dec 16, 2021	IDA-65970	Int Charges	19,340.18
Dec 16, 2021	IDA-65970	Int Charges	19,340.18
Dec 16, 2021	IDA-68370	Int Charges	600.72
Dec 16, 2021	IDA-68370	Int Charges	600.72
Dec 16, 2021	IDA-68370	Int Charges	5,289.15
Dec 16, 2021	IDA-68370	Int Charges	5,289.15
May 13, 2022	IDA-68370	Loan Disb	202,481.86
Jun 15, 2022	IDA-65970	Int Charges	196.12
Jun 15, 2022	IDA-65970	Int Charges	196.12
Jun 15, 2022	IDA-65970	Int Charges	18,231.02
Jun 15, 2022	IDA-65970	Int Charges	18,231.02
Jun 15, 2022	IDA-65970	Int Charges	-25.94
Jun 15, 2022	IDA-65970	Int Charges	25.94
Jun 15, 2023	IDA-65970	Int Charges	753.60
Jun 15, 2023	IDA-65970	Int Charges	18,466.02
Jun 15, 2023	IDA-65970	Int Charges	18,466.02
Dec 15, 2023	IDA-65970	Int Charges	17,836.70
Dec 15, 2023	IDA-65970	Int Charges	17,836.70
Dec 15, 2023	IDA-68370	Int Charges	226.97
Dec 15, 2023	IDA-68370	Int Charges	226.97
Dec 15, 2023	IDA-68370	Int Charges	16,953.77
Nov 30, 2021	IDA-68370	Loan Disb	8,856.22
Nov 30, 2021	IDA-68370	Loan Disb	90,579.73
Jul 27, 2022	IDA-68370	Loan Disb	146,945.97
Jun 15, 2022	IDA-68370	Int Charges	15.12
Jun 15, 2022	IDA-68370	Int Charges	15.12
Jun 15, 2022	IDA-68370	Int Charges	7,599.17
Jun 15, 2022	IDA-68370	Int Charges	7,599.17
Jul 30, 2021	IDA-65970	Loan Cancel	14,835.36
Apr 16, 2021	IDA-68370	Loan Disb	500,000.00
Jun 21, 2021	IDA-68370	Loan Disb	751,312.94
Aug 5, 2021	IDA-68370	Loan Disb	145,168.20
Apr 29, 2020	IDA-65970	Loan Disb	2,098,415.80
May 7, 2020	IDA-65970	Loan Disb	20,000.00
Jun 26, 2020	IDA-65970	Loan Disb	480,000.00
Jul 30, 2020	IDA-65970	Loan Disb	2,107,501.50
Jun 15, 2021	IDA-65970	Int Charges	348.35
Jun 15, 2021	IDA-65970	Int Charges	348.35
Jun 15, 2021	IDA-65970	Int Charges	19,763.65
Jun 15, 2021	IDA-65970	Int Charges	19,763.65
Dec 15, 2020	IDA-65970	Int Charges	2,136.88
Dec 15, 2020	IDA-65970	Int Charges	2,136.88
Nov 29, 2022	IDA-68370	Loan Disb	757,592.25
Nov 21, 2022	IDA-68370	Loan Disb	102,784.78
Nov 28, 2022	IDA-68370	Loan Disb	191,792.16
Dec 15, 2022	IDA-68370	Int Charges	59.09
Dec 15, 2022	IDA-68370	Int Charges	59.09
Dec 15, 2022	IDA-68370	Int Charges	9,077.06
Dec 15, 2022	IDA-68370	Int Charges	9,077.06
Sep 22, 2022	IDA-68370	Loan Disb	9,880.15
Sep 15, 2022	IDA-68370	Loan Disb	73,808.58
Sep 15, 2022	IDA-68370	Loan Disb	77,644.47
Sep 22, 2022	IDA-68370	Loan Disb	65,038.52
Nov 14, 2022	IDA-68370	Loan Disb	109,309.80
Apr 13, 2022	IDA-68370	Loan Disb	183,572.56
Dec 15, 2021	IDA-68370	Loan Disb	192,151.52
Dec 15, 2021	IDA-68370	Loan Disb	99,030.98
Dec 6, 2021	IDA-68370	Loan Disb	67,900.77
Dec 16, 2021	IDA-65970	Int Charges	144.52
Dec 16, 2021	IDA-65970	Int Charges	144.52

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name	Review	Date
Overall Implementation Progress (IP)	Highly Satisfactory	2024-11-13
Progress towards achievement of PDO	Highly Satisfactory	2024-11-13
Procurement	Satisfactory	2024-11-13
Financial Management	Highly Satisfactory	2024-11-13
Project Management	Highly Satisfactory	2024-11-13
Monitoring and Evaluation	Satisfactory	2024-11-13
Procurement	Satisfactory	2024-11-13
Project Management	Highly Satisfactory	2024-11-13
Financial Management	Moderately Satisfactory	2024-11-13
Progress towards achievement of PDO	Highly Satisfactory	2024-11-13
Monitoring and Evaluation	Satisfactory	2024-11-13
Overall Implementation Progress (IP)	Highly Satisfactory	2024-11-13

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Percentage of suspected cases of COVID-19 tested per approved protocol Value 0.00 100.00 85.00
Date March 20, 2020 September 21, 2022 March 31, 2021
Comment
National virology laboratory equipped with COVID-19 diagnostic equipment, test kits, and reagents per Ministry of Health guidelines Value No Yes Yes
Date March 20, 2020 December 5, 2020 March 31, 2021
Comment
Percentage of diagnosed cases treated per approved protocol Value 0.00 100.00 50.00
Date March 20, 2020 September 21, 2022 March 31, 2021
Comment
Population vaccinated, which is included in the priority population targets defined in national plan [by sex]. Value 0.00 98.70 100.00
Date December 31, 2021 March 28, 2024 December 31, 2024
Comment
Females Value 0.00 48.39 45.00
Date February 1, 2021 June 15, 2023 March 31, 2022
Comment
Adult population fully vaccinated [by sex]; Value 0.00 86.53 70.00
Date December 31, 2020 June 15, 2023 December 31, 2021
Comment
Females Value 0.00 42.39 40.00
Date February 1, 2021 June 15, 2023 December 31, 2022
Comment

INTERMEDIATE RESULTS INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Percentage of health districts with pandemic preparedness and response plans per Ministry of Health Guidelines Value 18.00 100.00 100.00
Date March 20, 2020 September 21, 2022 March 31, 2021
Comment
Percentage of claims registered in the Project's grievance redress mechanism (GRM) resolved in a timely manner Value 0.00 100.00 40.00
Date March 20, 2020 June 15, 2023 March 31, 2021
Comment

Percentages of health facilities with personal protective equipment and infection control products and supplies, without stock-outsin preceding two weeks	Value	32.00	100.00	100.00
	Date	March 20, 2020	September 21, 2022	March 31, 2021
	Comment

Country has prepared a referral system to care for COVID-19 patients Value No Yes Yes
Date March 20, 2020 December 5, 2020 April 30, 2020
Comment
Number of additional ICU beds equipped and operational Value 0.00 20.00 20.00
Date March 20, 2020 September 21, 2022 March 31, 2021
Comment
Protective personal equipment (PPE) distributed to the general population Value 0.00 100000.00 100000.00
Date April 2, 2020 December 5, 2020 October 30, 2020
Comment
Number of additional intermediary care beds equipped and operational in Sal and Boa Vista Islands Value 0.00 10.00 20.00
Date January 22, 2021 March 28, 2024 December 31, 2024
Comment
National COVID-19 Immunization Plan Developed and Approved Value No Yes Yes
Date January 22, 2021 February 18, 2021 March 12, 2021
Comment

Essential and frontline health workers benefitting from the first phase of the vaccine who are women (as percentage of the total women among essential and frontline health workers)	Value	0.00	100.00	100.00
	Date	January 22, 2021	September 21, 2022	June 30, 2021
	Comment

Pharmacovigilance System (PVS) adapted to detect Adverse Events Following Vaccination (AEFI) for the COVID19 vaccine Value No Yes Yes
Date January 22, 2021 June 11, 2021 February 26, 2021
Comment

Communication/Community engagement campaigns produced and implemented focusing on COVID-19 prevention activities and vaccine hesitancy among target priority groups	Value	1.00	2.00	2.00
	Date	April 1, 2021	September 21, 2022	December 31, 2022
	Comment

Digital platform operational to receive individual vaccination data Value No Yes Yes
Date June 23, 2021 September 21, 2022 December 31, 2022
Comment

Females	Value	0.00	48.39	45.00
	Date	February 1, 2021	June 15, 2023	March 31, 2022
	Comment

Percentage of health districts with pandemic preparedness and response plans per Ministry of Health Guidelines	Value	18.00	100.00	100.00
	Date	March 20, 2020	September 21, 2022	March 31, 2021
	Comment

Pharmacovigilance System (PVS) adapted to detect Adverse Events Following Vaccination (AEFI) for the COVID19 vaccine	Value	No	Yes	Yes
	Date	January 22, 2021	June 11, 2021	February 26, 2021
	Comment

Cabo Verde: COVID-19 Emergency Response Project

Abstract*

Development Objective

Key Details

Project Details

Sectors

Themes

Stay Connected, sign up for our:

Project Map

Finances

Financing Plan (US$ Millions)

Total Project Financing (US$ Millions)

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

Detailed Financial Activity as of March 31, 2025

Ratings

IMPLEMENTATION RATINGS

COMPLETION RATINGS

INDEPENDENT EVALUATION RATINGS

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INTERMEDIATE RESULTS INDICATORS